×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

1st incathlab Scientific Board meeting

The incathlab team is willing to keep providing with its members up-to-date operative techniques, training and information from international expert contributors. It is in this perspective of evolution that a Scientific Board has been established. On Wednesday May 20th, the 1st scientific...

Incathlab wishes you a Happy New Year 2015

We are very pleased for having welcomed 10 000 incathlab members in 2014 During the past year, we went on 10 worldwide events in the coronary and endovascular field and we produced over 130 new recorded cases and 20 live broadcasts in 30 european centers. We continue to remain an...

Season's Greetings

incathlab wishes you all the best for 2014! We are very pleased for having welcomed more than 110 000 visitors and followers on incathlab during the past year 2013. Having produced over 100 new recorded cases and 20 live broadcasts in the coronary and endovascular field we continue to remain...

Interview with Dr. Max Amor, Founder and Chief Medical Editor of Incathlab

Dr. Amor, you are Founder and Chief Medical Editor of www.incathlab.com, an e-learning platform for physicians and practitioners that, by the meanwhile, well-evolved and offers a great range of video cases on the field of interventional cardiology and radiology documenting basic up to...

Interview with Dr Alain Cribier, MD

Since the beginning of TAVI, indications have shifted from compassionate to high risk patients. What are in 2011 the good candidates for TAVI ? It is true than over the last 9 years, the indications have been cautiously extended from companionate cases (I-REVIVE trial, RECAST trial) to high...

Scroll Up